PDL Biopharma
PDLI
#8502
Rank
โ‚น26.74 B
Marketcap
โ‚น234.18
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -โ‚น9.63 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are โ‚น80.61 Million. In 2019 the company made an earning of -โ‚น5.91 Billion a decrease over its 2018 earnings that were of -โ‚น4.15 Billion.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-โ‚น9.63 Billion62.78%
2019-โ‚น5.91 Billion42.43%
2018-โ‚น4.15 Billion-121.38%
2017โ‚น19.41 B60.41%
2016โ‚น12.10 B-77.09%
2015โ‚น52.82 B3.09%
2014โ‚น51.24 B26.65%
2013โ‚น40.45 B19.82%
2012โ‚น33.76 B3.68%
2011โ‚น32.56 B77.17%
2010โ‚น18.38 B-35.29%
2009โ‚น28.40 B23.45%
2008โ‚น23.01 B-1751.42%
2007-โ‚น1.4 Billion-88.56%
2006-โ‚น12.18 Billion93.73%
2005-โ‚น6.29 Billion13.63%
2004-โ‚น5.54 Billion32.12%
2003-โ‚น4.19 Billion87.44%
2002-โ‚น2.24 Billion-302.45%
2001โ‚น1.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น3.185 T-25,637.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น975.28 B-7,919.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.46 Billion-16.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น3.30 B-126.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-โ‚น14.52 Billion 16.39%๐Ÿ‡บ๐Ÿ‡ธ USA